These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12452859)

  • 41. Dermatitis herpetiformis: IgA deposits in gingiva, buccal mucosa, and skin.
    Nisengard RJ; Chorzelski T; Maciejowska E; Kryst L
    Oral Surg Oral Med Oral Pathol; 1982 Jul; 54(1):22-5. PubMed ID: 6750497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Juvenile dermatitis herpetiformis: an immunoelectron microscopic study.
    Pehamberger H; Konrad K; Holubar K
    Br J Dermatol; 1979 Sep; 101(3):271-7. PubMed ID: 389268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH; van der Steen LPE; Korthouwer RM; Hage JJ; Langedijk JPM; Benschop JJ; Bakema JE; Slootstra JW; van Egmond M
    Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dermatitis herpetiformis: problems, progress and prospects.
    Fry L
    Eur J Dermatol; 2002; 12(6):523-31. PubMed ID: 12459520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.
    Cardones AR; Hall RP
    Immunol Allergy Clin North Am; 2012 May; 32(2):263-74, vi. PubMed ID: 22560139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA.
    Van Spriel AB; Leusen JH; Vilé H; Van De Winkel JG
    J Immunol; 2002 Oct; 169(7):3831-6. PubMed ID: 12244179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of proliferative response by gluten-specific T cells in the blood and gut of patients with dermatitis herpetiformis.
    Baker BS; Garioch JJ; Bokth S; Thomas H; Walker MM; Leonard JN; Fry L
    J Autoimmun; 1995 Aug; 8(4):561-74. PubMed ID: 7492350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterations.
    Smith SB; Harrist TJ; Murphy GF; Halperin AJ; Newell JB; Fallon JT; Fine JD; Mihm MC
    Arch Dermatol; 1984 Mar; 120(3):324-8. PubMed ID: 6367664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
    Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
    Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure to detect specific gluten antigens associated with the immune aggregates in the skin in dermatitis herpetiformis.
    Eterman KP; Nefkens MJ; van der Meer JB
    Arch Dermatol Res (1975); 1977 Dec; 260(3):247-52. PubMed ID: 74984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH; van Egmond M
    Eur J Clin Invest; 2017 Feb; 47(2):184-192. PubMed ID: 28024097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.
    Marietta E; Black K; Camilleri M; Krause P; Rogers RS; David C; Pittelkow MR; Murray JA
    J Clin Invest; 2004 Oct; 114(8):1090-7. PubMed ID: 15489956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
    Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
    J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgA and C3 complement in the uninvolved skin in dermatitis herpetiformis after gluten withdrawal.
    Fry L; Haffenden G; Wojnarowska F; Thompson BR; Seah PP
    Br J Dermatol; 1978 Jul; 99(1):31-7. PubMed ID: 678463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linear IgA disease in adults.
    Leonard JN; Haffenden GP; Ring NP; McMinn RM; Sidgwick A; Mowbray JF; Unsworth DJ; Holborow EJ; Blenkinsopp WK; Swain AF; Fry L
    Br J Dermatol; 1982 Sep; 107(3):301-16. PubMed ID: 7052113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Japanese case of the fibrillar type of dermatitis herpetiformis.
    Shimizu K; Hashimoto T; Fukuda T; Watanabe K; Ishiko A; Niizeki H; Shimizu H; Zone JJ; Nishikawa T
    Dermatology; 1995; 191(2):88-92. PubMed ID: 8520073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils.
    Hendrix JD; Mangum KL; Zone JJ; Gammon WR
    J Invest Dermatol; 1990 May; 94(5):667-72. PubMed ID: 2182721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dermatitis herpetiformis: the skin and the gut.
    Katz SI; Hall RP; Lawley TJ; Strober W
    Ann Intern Med; 1980 Dec; 93(6):857-74. PubMed ID: 7447195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dermatitis Herpetiformis Refractory to Gluten-free Dietary Treatment.
    Hervonen K; Salmi TT; Ilus T; Paasikivi K; Vornanen M; Laurila K; Lindfors K; Viiri K; Saavalainen P; Collin P; Kaukinen K; Reunala T
    Acta Derm Venereol; 2016 Jan; 96(1):82-6. PubMed ID: 26084552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.